2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4- ((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1): a potent, orally active, morpholine-based human neurokinin-1 receptor antagonist
- J Med Chem. 1996 Apr 26;39(9):1760-2. doi: 10.1021/jm950654w.
Affiliations
- 1. Merck Research Laboratories, Rahway, New Jersey 07065, USA.
PMID: 8627597
DOI: 10.1021/jm950654w